Provided by Tiger Trade Technology Pte. Ltd.

3SBIO

17.830
+1.3308.06%
Volume:71.33M
Turnover:1.27B
Market Cap:45.11B
PE:4.45
High:18.650
Open:16.420
Low:16.200
Close:16.500
52wk High:36.264
52wk Low:14.594
Shares:2.53B
HK Float Shares:2.53B
Volume Ratio:2.49
T/O Rate:2.82%
Dividend:0.26
Dividend Rate:1.47%
EPS(LYR):4.002
ROE:35.88%
ROA:22.68%
PB:1.40
PE(LYR):4.45
PS:2.16

Loading ...

Zhongtai Securities Maintains "Buy" on 3SBIO, Citing Unlocked Market Value Potential

Deep News
·
May 17

Zhongtai Securities Reiterates "Buy" Rating on 3SBIO (01530), Citing Early-Stage Pipeline with Multiple Potential First-in-Class Candidates for US-China Dual Submissions

Stock News
·
May 15

3SBIO Maintains "Buy" Rating from China Post Securities as Global Value Accelerates Through Multiple Clinical Trials

Stock News
·
May 12

3SBio Adds 34,000 Shares in April After Option Exercises, Keeps Public Float Above 25%

Bulletin Express
·
May 06

Stock Track | 3SBIO Soars 6.03% Intraday as SSS68 Injection Receives IND Approval for Three Indications

Stock Track
·
Apr 30

3SBIO Shares Surge Over 5% as SSS68 Injection Receives IND Approval for Three Indications in China

Stock News
·
Apr 30

三生制药2025年收入近177亿元,核心产品与全球合作驱动业绩大幅增长

Bulletin Express
·
Apr 29

3SBIO 2025 ESG Report: A-Level Rating, 48.49% Cut in Carbon Intensity and Full Anti-Corruption Coverage

Bulletin Express
·
Apr 29

3SBio Shifts to Full Electronic Distribution of Corporate Communications, Urges Non-Registered Shareholders to Submit Email Details

Bulletin Express
·
Apr 29

3SBio Issues Reminder to Shareholders on Shift to Electronic Corporate Communications

Bulletin Express
·
Apr 29

3SBio publishes 2025 annual report

Reuters
·
Apr 29

3SBio shareholders approved conditional Mandi share distribution at extraordinary general meeting

Reuters
·
Apr 23

Stock Track | 3SBIO Plummets 13.14% Intraday Amid Broader Biotech Selloff as Geopolitical Tensions and Oil Prices Dampen Rate Cut Hopes

Stock Track
·
Apr 23

Biopharma Stocks Slide Across Board as Oil Prices Squeeze Rate Cut Prospects

Stock News
·
Apr 23

CMB International Reports Moderate Recovery in Healthcare Sector Risk Appetite, Recommends Six Stocks Including Hansoh Pharma

Stock News
·
Apr 20

Stock Track | 3SBIO Soars 5.30% Intraday on Clinical Trial Approval and Institutional Endorsement

Stock Track
·
Apr 17

3SBIO Shares Surge Over 9% Afternoon on Domestic Clinical Approval for SSGJ-707 in Lung and Kidney Cancers

Stock News
·
Apr 15

Stock Track | 3SBIO Soars 5.12% Intraday on Dual IND Approval for SSS67 and Pfizer Partnership

Stock Track
·
Apr 15

Morgan Stanley Cuts 3SBIO (01530) Target Price to HK$34, Keeps "Overweight" Rating

Stock News
·
Apr 14

Stock Track | 3SBio Soars 5.05% Intraday on Strong 2025 Earnings and Undervaluation Appeal

Stock Track
·
Apr 13